BlackRock Fund Advisors’s Inovio Pharmaceuticals INO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $22M | Buy |
263,805
+28,853
| +12% | +$2.4M | ﹤0.01% | 2130 |
|
|
2016
Q3 | $26.3M | Buy |
234,952
+12,212
| +5% | +$1.37M | 0.01% | 1939 |
|
|
2016
Q2 | $24.7M | Sell |
222,740
-10,982
| -5% | -$1.22M | 0.01% | 1915 |
|
|
2016
Q1 | $24.4M | Buy |
233,722
+3,144
| +1% | +$329K | 0.01% | 1870 |
|
|
2015
Q4 | $18.6M | Sell |
230,578
-10,233
| -4% | -$825K | ﹤0.01% | 2091 |
|
|
2015
Q3 | $16.7M | Buy |
240,811
+6,240
| +3% | +$433K | ﹤0.01% | 2108 |
|
|
2015
Q2 | $23M | Buy |
234,571
+31,437
| +15% | +$3.08M | 0.01% | 2030 |
|
|
2015
Q1 | $19.9M | Buy |
203,134
+4,507
| +2% | +$441K | ﹤0.01% | 2075 |
|
|
2014
Q4 | $21.9M | Buy |
198,627
+79,000
| +66% | +$8.7M | 0.01% | 2022 |
|
|
2014
Q3 | $14.1M | Sell |
119,627
-3,896
| -3% | -$461K | ﹤0.01% | 2163 |
|
|
2014
Q2 | $16M | Buy |
+123,523
| New | +$16M | ﹤0.01% | 2137 |
|